Search clinical trials for: BioChaperone® Combo

Total 13787 results

Adocia

Completed

A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Germany
Adocia

Completed

A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Adocia

Completed

Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Gen-Probe, Incorporated

Terminated

Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays

Gonorrhea | Chlamydia Infections | Trichomonas Infections

United States
Guangzhou Wondfo Biotech Co., Ltd
Nova Clinical Solutions, Inc.

Completed

Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test (Preview® hCG)

Pregnancy

United States
Adocia

Completed

A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes

Diabetes Mellitus Type 1

Germany
Adocia

Completed

A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM

Type 1 Diabetes Mellitus

Germany
Adocia
Eli Lilly and Company

Completed

An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects

Healthy

Germany
Adocia

Completed

A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers

Healthy

Germany
Adocia

Completed

A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

Type1 Diabetes Mellitus

Germany
Adocia
Eli Lilly and Company

Completed

To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Chinese University of Hong Kong

Completed

"COMBO-KEY" - A Home Visiting and Phone Coaching Programme to Promote Stroke Survivors' Recovery

Stroke

Hong Kong
Adocia

Completed

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal

Diabetes Mellitus Type 1

Germany
Adocia
Eli Lilly and Company

Completed

A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®

Type 1 Diabetes Mellitus

Germany
Adocia
Eli Lilly and Company

Completed

A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
University of Texas at Austin

Recruiting

Empowering Students Project

Relationship, Social

United States
Adocia

Completed

A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes

Diabetes Mellitus Type 1

Germany
Gateway Health Alliance

Completed

The Use of Irvingia Gabonensis (Bush Mango)and Cissus Quadrangularis to Reduce Weight and Blood Lipids

Obesity | Overweight | Dyslipidemia
Adocia

Completed

A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Germany
University of Virginia
National Institutes of Health (NIH); National Institute on Aging (NIA)

Recruiting

PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction

Heart Failure With Reduced Ejection Fraction

United States
Adocia

Completed

A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes

Diabetes Mellitus Type 1

Germany
Virchow Group
Adocia

Completed

Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer

Diabetic Foot Ulcers

India
Prof. Stephen Lee

Completed

OCT Evaluation of Healing of COMBO Stent (EGO-COMBO)

Coronary Thrombosis | Coronary Restenosis

Hong Kong
University Ghent

Withdrawn

Online Contingent Attention Training (OCAT)

Major Depression in Remission

Belgium
Gen-Probe, Incorporated

Completed

Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System

Chlamydia Trachomatis | Neisseria Gonorrhoeae Infection

United States
Adocia

Completed

A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM

Type 1 Diabetes Mellitus

Germany
Hemex Health

Recruiting

Gazelle COVID-19 Test Clinical Accuracy Protocol

Covid19

United States
Adocia
Tonghua Dongbao Pharmaceutical Co.,Ltd

Completed

A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes

Type 1 Diabetes

Germany
Hoffmann-La Roche

Completed

Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus Calculators

Diabetes Mellitus Type 1

Germany
Adocia
Tonghua Dongbao Pharmaceutical Co.,Ltd

Completed

A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and Lantus® in Healthy Chinese Volunteers

Healthy

Germany
Gisela Grotewold Chelimsky

Terminated

A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders

Dyspepsia | Nausea | Irritable Bowel Syndrome | Functional Gastrointestinal Disorders | Vagus Nerve Autonomic Disorder

United States
Calithera Biosciences, Inc

Completed

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Renal Cell Carcinoma | Non Small Cell Lung Cancer | Mesothelioma | Solid Tumors | Triple-Negative Breast Cancer | Fumarate Hydratase (FH)-Deficient Tumors | Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST) | Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal... and other conditions

United States
Pfizer

Completed

Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy (ASSIAL)

Ankylosing Spondylitis

Italy
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Resistance and Aerobic Exercise on Cardiovascular Health (STRRIDE2)

Heart Diseases | Cardiovascular Diseases | Obesity | Insulin Resistance | Hyperlipidemia | Metabolic Syndrome X

United States
Nyamdavaa Tuul

Not yet recruiting

Phase I Study of Combined Immune Cell Therapy in Patients With Stage 4 Colorectal Cancer With Metastatic Lesion Who Failed Prior Standard of Care

Metastatic Colorectal Cancer | Colorectal Cancer Stage IV
Gen-Probe, Incorporated

Completed

Prospective Collection of Female and Male Specimens for PANTHER® System Testing

Gonorrhea | Chlamydia Infections

United States
Abbott Diagnostics Division

Completed

Evaluation of Diagnostic HIV Ag/Ab Combo Assay

Human Immunodeficiency Viruses

United States
Vrije Universiteit Brussel

Not yet recruiting

Cognitive Model for Behavioral Interventions as a Personalized Intervention for Patients With Serious Mental Illness

Psychiatric Disorder
University Children's Hospital, Zurich

Completed

Comparing Forearm and Upper Arm Combi Cast for Distal Forearm Fractures in Children

Radius Fractures | Forearm Fracture | Salter-Harris Type I | Salter-Harris Type 2

Switzerland
Adocia
Tonghua Dongbao Pharmaceutical Co.,Ltd

Completed

A Trial Investigating the Dose Linearity and Safety of BC Combo THDB0207 in Subjects With Type 2 Diabetes

Type 2 Diabetes

Germany
American University
Trichotillomania Learning Center

Completed

Efficacy of COMB (Comprehensive Behavioral) Model of Treatment of Trichotillomania

Trichotillomania | Hair-Pulling Disorder

United States
A-Spine Asia Co., Ltd.

Recruiting

Post-Market Clinical Follow-up Study of A-SPINE's Products

Trauma | Scoliosis | Degenerative Disc Disease | Tumor | Stenosis | Kyphosis | Deformity | Pseudoarthrosis of Spine

Taiwan
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Effect of Cock's Comb Extract in the Treatment of Arsenical Skin Lesion

Chronic Arsenic Poisoning

Bangladesh
Rabin Medical Center
Hoffmann-La Roche

Completed

Accu-Chek Combo in Young Patients

Type 1 Diabetes

Israel
Mativa-Tech SA

Recruiting

Interest in "Combo" (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement (ICAN)

NASH - Nonalcoholic Steatohepatitis

France
Prof. Stephen Lee

Completed

EGO-COMBO Angiographic Extension Study

Coronary Disease

China
OrbusNeich
Icahn School of Medicine at Mount Sinai

Completed

MASCOT - Post Marketing Registry (MASCOT)

Coronary Artery Disease | Atherosclerosis

Netherlands
The University of Hong Kong

Completed

EGO-COMBO Clinical End-point Extension Study Beyond 36 Months

Coronary Restenosis

China

3

Subscribe